26 Jul 2021 --- Azelis is entering into a new distribution agreement with SPI Pharma, a pharmaceutical solutions supplier for formulation marketers. Azelis will distribute SPI Pharma’s product line in the UK and Ireland.The deal is the latest in a series of acquisitions and agreements expanding Azelis’ footprint across international markets and segments. This new partnership between Azelis and SPI Pharma extends the organoleptic excipients in Azelis’ range, complementing the existing starch derivatives and sugars, flavors and sucralose.
